Kiromic BioPharma, Inc. (KRBP)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 03:48PM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 234.07k |
| Enterprise value | 7.20M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 11.55 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.37 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.68 |
| 52-week change 3 | -97.30% |
| S&P500 52-week change 3 | 14.78% |
| 52-week high 3 | 9.3000 |
| 52-week low 3 | 0.1600 |
| 50-day moving average 3 | 0.2632 |
| 200-day moving average 3 | 2.4592 |
Share statistics
| Avg vol (3-month) 3 | 8.52k |
| Avg vol (10-day) 3 | 2.5k |
| Shares outstanding 5 | 1.26M |
| Implied shares outstanding 6 | 1.26M |
| Float 8 | 572.94k |
| % held by insiders 1 | 3.91% |
| % held by institutions 1 | 68.50% |
| Shares short (30 Aug 2023) 4 | 45.74k |
| Short ratio (30 Aug 2023) 4 | 1.45 |
| Short % of float (30 Aug 2023) 4 | 6.82% |
| Short % of shares outstanding (30 Aug 2023) 4 | 3.89% |
| Shares short (prior month 30 Jul 2023) 4 | 62.44k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 12 Mar 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -98.81% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -19.32M |
| Net income avi to common (ttm) | -24.99M |
| Diluted EPS (ttm) | -19.5100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.38M |
| Total cash per share (mrq) | 3.48 |
| Total debt (mrq) | 11.35M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.34 |
| Book value per share (mrq) | -3.82 |
Cash flow statement
| Operating cash flow (ttm) | -19.92M |
| Levered free cash flow (ttm) | -14.6M |
© 2023 Yahoo. All rights reserved.